ATE435022T1 - Mässigung der wirkung von endotoxinen - Google Patents

Mässigung der wirkung von endotoxinen

Info

Publication number
ATE435022T1
ATE435022T1 AT04790307T AT04790307T ATE435022T1 AT E435022 T1 ATE435022 T1 AT E435022T1 AT 04790307 T AT04790307 T AT 04790307T AT 04790307 T AT04790307 T AT 04790307T AT E435022 T1 ATE435022 T1 AT E435022T1
Authority
AT
Austria
Prior art keywords
endotoxins
modification
effects
Prior art date
Application number
AT04790307T
Other languages
English (en)
Inventor
Irene Corthesy-Theulaz
Grigorios Fotopoulos
Gabriela Bergonzelli
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34354433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE435022(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Application granted granted Critical
Publication of ATE435022T1 publication Critical patent/ATE435022T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AT04790307T 2003-10-13 2004-10-12 Mässigung der wirkung von endotoxinen ATE435022T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03023016 2003-10-13
PCT/EP2004/011416 WO2005039606A2 (en) 2003-10-13 2004-10-12 Moderating the effect of endotoxins

Publications (1)

Publication Number Publication Date
ATE435022T1 true ATE435022T1 (de) 2009-07-15

Family

ID=34354433

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04790307T ATE435022T1 (de) 2003-10-13 2004-10-12 Mässigung der wirkung von endotoxinen

Country Status (17)

Country Link
US (1) US8216605B2 (de)
EP (1) EP1675601B2 (de)
JP (1) JP4918361B2 (de)
CN (2) CN102319417B (de)
AR (1) AR047763A1 (de)
AT (1) ATE435022T1 (de)
BR (1) BRPI0415385A (de)
CA (1) CA2542448A1 (de)
DE (1) DE602004021831D1 (de)
DK (1) DK1675601T4 (de)
ES (1) ES2328149T5 (de)
IL (1) IL174978A0 (de)
MY (1) MY140220A (de)
PT (1) PT1675601E (de)
TW (1) TW200520696A (de)
WO (1) WO2005039606A2 (de)
ZA (1) ZA200603824B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0415388A (pt) * 2003-10-13 2006-12-12 Nestec Sa moderação do efeito das endotoxinas
CN113729228A (zh) * 2020-05-29 2021-12-03 安琪纽特股份有限公司 用于预防或改善腹泻的组合物及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US177534A (en) * 1876-05-16 Improvement in meat-extracts
US4595590A (en) * 1984-01-17 1986-06-17 Laboratoires Biocodex Method for preventing or treating pseudo-membranous colitis
JPS61236727A (ja) * 1985-04-12 1986-10-22 Advance Res & Dev Co Ltd 抗う蝕乃至抗菌周症剤
JP2805490B2 (ja) † 1989-02-07 1998-09-30 雪印乳業株式会社 細菌毒素中和剤
CN1056750C (zh) * 1993-12-10 2000-09-27 济南三株药业有限公司 一种营养保健口服液及其制法
US5550106A (en) * 1994-03-04 1996-08-27 Bristol-Myers Squibb Company Low buffer nutritional composition
RU2168915C2 (ru) * 1996-03-19 2001-06-20 Алтайский научно-исследовательский проектно-технологический институт животноводства Мясной продукт для детского питания
US7374753B1 (en) * 1997-06-03 2008-05-20 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
JP2001008636A (ja) * 1999-06-30 2001-01-16 Tanabe Seiyaku Co Ltd 感染症防止用飼料組成物
JP2001055338A (ja) * 1999-08-13 2001-02-27 Kirin Brewery Co Ltd 酵母細胞壁画分からなる薬理用組成物
JP3307627B2 (ja) * 2000-02-09 2002-07-24 オク タイン 酵母ジゴサッカロマイシスロキシイ（Ｚｙｇｏｓａｃｃｈａｒｏｍｙｃｅｓｒｏｕｘｉｉ）からサイトカラシン（Ｃｙｔｏｃｈａｌａｓｉｎ）様物質群を製造する方法。
NL1014380C2 (nl) * 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
JP2002080351A (ja) 2000-09-07 2002-03-19 Natl Fedelation Of Agricult Coop Assoc 免疫増強剤
SE0003958D0 (sv) * 2000-10-31 2000-10-31 Biogaia Fermentation Ab Method for growth of microorganisms
FI114895B (fi) 2001-05-14 2005-01-31 Suomen Rehu Oy Ravinnon lisäaine
DE60232077D1 (de) † 2001-06-29 2009-06-04 Glykos Finland Oy Verwendung mindestens einer glycoinhibitor-substanz gegen infektionskrankheiten
WO2004003235A2 (en) * 2002-06-28 2004-01-08 Puleva Biotech, S.A. Probiotic strains, a process for the selection of them, compositions thereof, and their use
WO2004002495A1 (en) † 2002-06-28 2004-01-08 Glykos Finland Oy Therapeutic compositions for use in prophylaxis or treatment of diarrheas
ATE339114T1 (de) * 2002-07-23 2006-10-15 Wrigley W M Jun Co Verkapselte aromastoffe und kaugummi damit
BRPI0415388A (pt) † 2003-10-13 2006-12-12 Nestec Sa moderação do efeito das endotoxinas

Also Published As

Publication number Publication date
WO2005039606A3 (en) 2005-09-15
CN1886144A (zh) 2006-12-27
IL174978A0 (en) 2006-08-20
DK1675601T4 (da) 2013-05-06
US20070122453A1 (en) 2007-05-31
TW200520696A (en) 2005-07-01
CA2542448A1 (en) 2005-05-06
CN102319417A (zh) 2012-01-18
BRPI0415385A (pt) 2006-12-12
ZA200603824B (en) 2007-07-25
EP1675601B1 (de) 2009-07-01
CN102319417B (zh) 2014-08-13
EP1675601A2 (de) 2006-07-05
ES2328149T3 (es) 2009-11-10
JP4918361B2 (ja) 2012-04-18
PT1675601E (pt) 2009-08-31
WO2005039606A2 (en) 2005-05-06
US8216605B2 (en) 2012-07-10
DK1675601T3 (da) 2009-11-09
ES2328149T5 (es) 2013-07-12
EP1675601B2 (de) 2013-04-10
MY140220A (en) 2009-12-31
DE602004021831D1 (de) 2009-08-13
JP2007527410A (ja) 2007-09-27
AR047763A1 (es) 2006-02-22

Similar Documents

Publication Publication Date Title
DK1661563T3 (da) Forbindelser der påvirker ghicokinase
SE0301569D0 (sv) Novel compounds
ATE399193T1 (de) Lösungsmittelhaltige beschichtungszusammensetzungen
FR2862654B1 (fr) Composition amylacee filmogene
DE502004004375D1 (de) Wäschetrockner
DK1492934T3 (da) Dørenhed
DE602004027792D1 (de) Indazolamide mit analgetischer wirkung
DE602004026773D1 (de) Verfahrensherstellung von ethern
DE60315984D1 (de) Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung
ATE444953T1 (de) Substituierte spirobenzazepine
FI20031304A0 (fi) Kuivauslaite
DE502004009935D1 (de) Substituierte dihydrochinazoline ii
ATE435022T1 (de) Mässigung der wirkung von endotoxinen
DE60235470D1 (de) N-heterocyclische inhibitoren der expression von tnf-alpha
DE502004001392D1 (de) Sprühanordnung
DE602004024640D1 (de) Reinigung von titantetrachlorid
FR2862871B1 (fr) Composition cosmetique anti-pollution
DE112004000410D2 (de) Sprühvorrichtung
ATE394370T1 (de) Von vitamin d abgeleitete monohalogenvinylverbindungen
DE602004016680D1 (de) N von tests
DE60323088D1 (de) Leberschützende wirkung der 10-o-p-hydroxybenzoylaucubin
DE502004006442D1 (de) Bauelement
DE602004000844D1 (de) Beschichtungszusammensetzungen
NO20035096L (no) Konstantstromventil
PT9874T (pt) Tabuleiros de secagem

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1675601

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 1675601

Country of ref document: EP